ACE and early-onset autosomal dominant Alzheimer disease: ApoE4 is considered a major genetic risk factor for late-onset and sporadic Alzheimer disease and incident memory decline, and there is evidence that ACE inhibitors are protective against the risk of Alzheimer’s disease in the absence of ApoE4, but not in the presence of the ApoE4 allele.